JIUN-KAE JACK LEE to Imatinib Mesylate
This is a "connection" page, showing publications JIUN-KAE JACK LEE has written about Imatinib Mesylate.
Connection Strength
0.039
-
Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma. Clin Lung Cancer. 2014 May; 15(3):197-201.
Score: 0.021
-
Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma. J Thorac Oncol. 2011 Dec; 6(12):2104-11.
Score: 0.018